U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07450976) titled 'A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer' on Feb. 27.
Brief Summary: This is a multicenter, Phase 2 clinical trial to evaluate the efficacy and safety, PK and immunogenicity of SHR-A1904 in patients with advanced or metastatic biliary tract cancer (BTC). Patients will treat with SHR-A1904 until unacceptable toxicity or disease progression.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Biliary Tract Cancer
Intervention:
DRUG: SHR-A1904 for Injection
SHR-A1904 for injection, different doses.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Suzhou Suncadia Biopharmace...